MORGAN STANLEY - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$641,915
+4857.6%
2,790,933
+7539.3%
0.00%
Q1 2023$12,948
-8.4%
36,534
-17.1%
0.00%
Q4 2022$14,133
-82.3%
44,044
-59.7%
0.00%
Q3 2022$80,000
-40.3%
109,343
-26.3%
0.00%
Q2 2022$134,000
-54.1%
148,442
-24.3%
0.00%
Q1 2022$292,000
-45.3%
196,165
-20.3%
0.00%
Q4 2021$534,000
+78.0%
246,169
+192.2%
0.00%
Q3 2021$300,000
-33.8%
84,238
+6.7%
0.00%
Q2 2021$453,000
+14.4%
78,970
+3.5%
0.00%
Q1 2021$396,000
+93.2%
76,335
-11.3%
0.00%
Q4 2020$205,000
+266.1%
86,108
+113.8%
0.00%
Q3 2020$56,000
-41.7%
40,284
-19.7%
0.00%
Q2 2020$96,000
+10.3%
50,144
+40.3%
0.00%
Q1 2020$87,000
-40.4%
35,751
-45.0%
0.00%
Q4 2019$146,000
+65.9%
64,979
+54.7%
0.00%
Q3 2019$88,000
+8.6%
42,016
+29.8%
0.00%
Q2 2019$81,000
-51.5%
32,379
-23.2%
0.00%
Q1 2019$167,000
+307.3%
42,172
+43.3%
0.00%
Q4 2018$41,000
-43.8%
29,437
+0.7%
0.00%
Q3 2018$73,000
+160.7%
29,222
+173.5%
0.00%
Q2 2018$28,000
-17.6%
10,683
-33.6%
0.00%
Q1 2018$34,000
-54.7%
16,082
+0.3%
0.00%
Q4 2017$75,0000.0%16,041
+62.6%
0.00%
Q3 2017$75,000
+134.4%
9,863
+60.2%
0.00%
Q2 2017$32,000
-15.8%
6,157
-4.6%
0.00%
Q1 2017$38,000
+137.5%
6,452
+181.5%
0.00%
Q4 2016$16,0002,292
+5630.0%
0.00%
Q3 2016$0
-100.0%
40
-95.9%
0.00%
Q2 2016$3,000
+50.0%
970
+92.8%
0.00%
Q1 2016$2,0005030.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders